ALLOS THERAPEUTICS INC 4
4 · ALLOS THERAPEUTICS INC · Filed Jul 5, 2005
Insider Transaction Report
Form 4
Malek Eric
VP of Corporate Development
Transactions
- Purchase
Common Stock
2005-06-30$1.85/sh+286$530→ 35,860 total
Holdings
- 13,250
Stock Options (Right to buy)
Exercise: $4.50From: 2002-07-17Exp: 2011-07-17→ Common Stock (13,250 underlying) - 15,960
Stock Options (Right to buy)
Exercise: $6.00From: 2003-03-01Exp: 2012-03-01→ Common Stock (15,960 underlying) - 25,000
Stock Options (Right to buy)
Exercise: $10.94From: 2001-06-15Exp: 2010-06-15→ Common Stock (25,000 underlying) - 50,000
Stock Options (Right to buy)
Exercise: $2.46From: 2006-06-04Exp: 2015-03-04→ Common Stock (50,000 underlying) - 31,400
Stock Options (Right to buy)
Exercise: $4.75From: 2003-04-03Exp: 2013-03-03→ Common Stock (31,400 underlying) - 12,880
Stock Options (Right to buy)
Exercise: $6.38From: 2002-03-01Exp: 2011-03-01→ Common Stock (12,880 underlying) - 15,000
Stock Options (Right to buy)
Exercise: $2.28From: 2005-03-08Exp: 2014-09-08→ Common Stock (15,000 underlying) - 30,000
Stock Options (Right to buy)
Exercise: $3.20From: 2003-07-03Exp: 2013-06-03→ Common Stock (30,000 underlying) - 17,584
Stock Options (Right to buy)
Exercise: $5.44From: 2005-03-01Exp: 2014-03-01→ Common Stock (17,584 underlying)